The Wharton Moneyball Post Game Podcast

Share

Wharton Moneyball: NFL Draft Trades, the Big Data Bowl, & Baseball Analytics

Ep. 141

Show from 3/13/19


In this episode of Wharton Moneyball the whole crew kicks off the show getting into NFL Draft, especially the news about the Giants trading Odell Beckham to the Browns! Then, the NFL hosted it's first Big Data Bowl where students from universities all over the country competed to find new, innovative ways to play the game of football. A Penn team consisting of _____ made it to the finals with a project on receiver routes and optimizing yardage. Two of them join the show to discuss their research. Plus the author of "Big Data Baseball" joins the show to discuss the development of sports science and player stats in MLB. All that and more


Guests:

Andrew Castle (Statistics) and Jake Flancer (Statistics & Decision Processes) - They are both sophomores studying Statistics at the Wharton School. They were part of a team from the Wharton Sports Research Group which was named one of four college-level finalists in the NFL’s first Big Data Bowl, and they presented their findings at the NFL Combine just two weeks ago. 

Their research can be found here: https://operations.nfl.com/media/3669/big-data-bowl-penn.pdf


Travis Sawchik – He’s an MLB reporter for FiveThirtyEight. He is the Author of Big Data Baseball and the Co-author of The MVP Machine which is set to be released in June. 

His writing can be found here: https://fivethirtyeight.com/contributors/travis-sawchik/

Follow him on Twitter: @Travis_Sawchik

More Episodes

7/22/2020

7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.